Filter by keyword: Filter by year:

Cutting the Biologics Red Tape or Cutting Corners: The Biosimilar Red Tape Elimination Act, Recent Changes in FDA Guidance, and the Future of Interchangeability

November 30, 2025

On June 4th, 2025, the Biosimilar Red Tape Elimination Act was reintroduced into Congress. This bill, now in its

The Fake News Feedback Loop: When AI Trains on Its Own Lies

November 23, 2025

What happens when a machine starts believing its own lies?

Generative AI was built

Big Tech's Pseudo-Acquisitions: Using Licensing and Hiring Agreements Instead of Outright M&As

March 24, 2025

humanoid creatures collecting company logos and organizing them on a table

Tech giants like Microsoft, Amazon, and Google are opting to pursue

Sovereignty or Protectionism: Balancing Technological Innovation and Protecting Citizens’ Fundamental Rights

February 27, 2025

mceclip1.jpg

Countries across the globe are reforming legal frameworks that were once greatly guided by protectionist policies. Countries are now embracing a more

Tearing a Page from Cybersecurity’s Playbook: What AI Regulation Can Learn from Cybersecurity

February 27, 2025

mceclip0-ec8ed987cf4190248ead5e123d1302e1.jpg

As artificial intelligence gains ubiquity, its use brings significant governance challenges. Across the world, many countries have responded to the new technology

The Collision Course Between Real-Time Bidding and GDPR: A Regulatory Reckoning for Ad Tech

February 24, 2025
 
mceclip1.png

The Mechanics of Real-Time Bidding

When we open a webpage, we are all familiar with the pop-up banners in the corners, displaying ads

Police and Facial Recognition Technology: How Innovation Can Threaten Privacy

December 4, 2024

Law enforcement officers in the United States are increasingly turning to a new technology to make their jobs easier: facial recognition

California’s Struggle to Regulate AI

November 4, 2024

While Artificial Intelligence continues to transform industries across the globe, legislators are still grappling with balancing technological innovation and public interest.

Cloned Companions: The Commercialization of Pet Cloning

October 28, 2024

“Marching-in” on Patent Rights: The Biden Administration’s Effort to Lower Pharmaceutical Prices

April 14, 2024

On December 7, 2023, the U.S. Department of Commerce’s National Institute of Standards and Technology (NIST) issued a notice-and-comment period for their new